Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) versus Clopidogrel in Asian/Japanese Patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS)

Study identifier:D5130C00027

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Randomised, Double-blind, Double-dummy, Parallel Group, International (Asian), Multicenter, Phase 3 Study to Assess Safety and Efficacy of AZD6140 on top of low dose Acetyl Salicylic Acid (ASA) versus Clopidogrel on top of low dose ASA in Asian/Japanese Patients with Non-ST or ST Elevation Acute Coronary Syndromes(ACS) for whom PCI is planned

Medical condition

Acute Coronary Syndrome

Phase

Phase 3

Healthy volunteers

No

Study drug

Ticagrelor, Clopidogrel, Acetylsalicylic acid ASA

Sex

All

Actual Enrollment

801

Study type

Interventional

Age

20 Years +

Date

Study Start Date: 01 Feb 2011
Primary Completion Date: 01 Jul 2012
Study Completion Date: 01 Jul 2012

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Oct 2015 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria